Publication | Open Access
The combination of epigenetic drugs SAHA and HCI-2509 synergistically inhibits EWS-FLI1 and tumor growth in Ewing sarcoma
29
Citations
37
References
2018
Year
The combination of SAHA and HCI-2509 is proposed as a novel treatment strategy for ES patients to inhibit the essential driver of this sarcoma and tumor growth.
| Year | Citations | |
|---|---|---|
Page 1
Page 1